ChartSmarter is a service dedicated to the art of technical analysis.

On a daily basis we write up actionable ideas on a specific, major S&P sector on both the long and short side, in an easy yet thorough way. In the notes we give precise entries and exits, while looking to capture the "meat" of a trend. Give us a try today with a 2 week FREE trial.

Monthly

$99monthly
  • Full Access to all of the Game Plans
  • First 2 weeks FREE, your account won't be charged until the trial period is over

Loyal Reader Special

$999yearly
  • Full Access to all of the Game Plans
  • First 2 weeks FREE, your account won't be charged until the trial period is over

Latest Chartsmarter Game Plans

21Feb 2020

Consumer Sector Review: 2/24/20

Friday|0 Comments

There Is No Place Like Home: With money pouring into bonds, as market participants around the world are starving for yield and parking their capital where it is treated best in the world, it is keeping bond yields depressed to say the least. This is certainly keeping a bid under the homebuilding group. The ITB is on a 3 week winning streak, and higher 6 of the last 7. This week it rose .5%, besting the S&P 500 which fell by 1.25%. DHI and LEN, the 2 largest holdings in the ITB that make up more than one quarter of the ETF, are having banner 2020's up 17 and 27% YTD respectively. The periphery plays are being supported by the underlying groups strength, with perhaps the best example being Home Depot. It rose fractionally this week by .1%, but now trades well above a cup base pivot of 239.41 taken out on 2/10. Even the toxic name Lumber Liquidators is on a 7 session winning streak jumping more than 32% this week (and that was with it CLOSING 12% off intraweek highs), not a typo.

20Feb 2020

Technology Sector Review: 2/21/20

Thursday|0 Comments

Recite The Alphabet: As the Nasdaq approaches the very round 10000 figure, currently about 2.5% away, one has to keep in mind just how robust this run has been. In 2020 thus far it has recorded back to back losing sessions, just once on in 1/24-27 which lost nearly a combined 3%. The argument that there is no where else to allocate capital too, and that liquidity controls markets still resonates clearly. Among the "big five" tech names, GOOGL seems to be holding up the best as of late. We did mention we thought FB was a short on an upside earnings gap fill from the 1/29 session, and that looks relevant thus far. Give AAPL and AMZN credit for just trading 2% off most recent all time highs, and MSFT could be the next one to soften in my humble opinion. The chart of GOOGL below is my favorite of the mega cap bunch. Each of the last 4 weeks seems to be digesting the 14 of 15 week winning streak the weeks ending between 10/11/19-1/17. Do not be surprised if this march continues higher in firm fashion, IF a breakout occurs.

19Feb 2020

Healthcare Sector Review: 2/20/20

Wednesday|0 Comments

Biotech Boogie: The group via the XBI seems to be gathering some steam as it demonstrates it is not afraid near the very round par number. It is above the double bottom pivot of 97.74, albeit fractionally so, and is higher by more than 1% this week, after rising 2% the week before, and 7% the week prior to that. It is gathering courage as it nears the round 100 number which has been pesky resistance. There have been some interesting developments in the space, with Warren Buffett making a purchase of BIIB. The chart is showing nice momentum, but it seems like an odd play for him, as I remember him a few years back saying he only invests in things he understands inside and out. It has been outperforming AMGN, which has been the king of the "big four" (CELG was bought out and GILD has been dead money for a few years). Bears will probably be proclaiming the Oracle's venture into the space is a sign of a top. As always ignore the chatter, and focus on PRICE action.